Zinc warning letter
This article was originally published in The Tan Sheet
Quantum Inc.'s claim positioning Common Cold & Flu Season Prevention Kit as an alternative to the flu and statements asserting that Thera Zinc lozenges "make the common cold disappear fast" drew a warning letter from FDA. The agency found fault with claims for 13 zinc and elderberry products that allegedly indicated the products for the diagnosis, cure, mitigation or prevention of disease...
You may also be interested in...
Roche/Genentech oncology partnering maintained a robust dealmaking pace through the pandemic, keeping the percentage of partnered R&D programs at about 50% of the cancer drug pipeline.
To mitigate pandemic disruption of component supply chains, the US FDA said it will downgrade some post-approval change categories for sterile drug container closure systems. The downgrade will cover drugs in shortage and those used to treat COVID-19.
“This is truly uncharted territory because we’ve never had this situation,” says CHPA regulatory VP David Spangle. Asking Congress instead to instruct FDA to first determine a safe daily limit would be a threatening precedent for the supplement market, says CRN CEO Steve Mister. “That really turns DSHEA on its head.”